GEA Group (G1A) investor relations material

Executive summary

• Guidance for FY2026 is confirmed: organic sales growth of 5%-7%, EBITDA margin before restructuring at 16.6%-17.2%, and ROCE between 34%-38%.

• Strong start to the year with 5.3% organic sales growth in Q1 and 6.4% organic order intake growth.

• Confidence in maintaining solid order intake and sales growth throughout 2026, supported by a robust pipeline across all order sizes.

• Dividend of €1.30 per share paid in May, totaling €212 million.

Trading performance and revenue trends

• Food segment remains strong, with poultry and protein-rich products driving growth.

• Beverage market shows improvement, especially in non-alcoholic beer and other non-alcoholic beverages.

• Dairy processing and farming are stable, with U.S. and large farms as growth drivers.

• Pharma continues to contribute positively, and new food segment is expected to progress further this year.

• Nutrition Plant Engineering expects sales acceleration after a slow Q1, aiming for 7%-9% organic growth for the year.

Profitability and margins

• Q1 EBITDA margin before restructuring was 16.2%; further improvement expected in Q2 and for the full year.

• Q2 2025 EBITDA margin was 16.5%; management targets ongoing margin improvement quarter over quarter.

• Full-year depreciation and amortization expected at €230 million; financial result at -€30 million; tax rate between 28%-30%.